Sales/Maturities of Investments

$20.46M

TTM · Period ending: Jun 30, 2026 · USD

Latest reported$20.46Mperiod endingJun 30, 2026

LCTX Sales/Maturities of Investments ($0.00 → $20.46M)

Annual Sales/Maturities of Investments

High-resolution chart · PNG

LCTX sales/maturities of investments history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Sales/Maturities of Investments — Annual fiscal periods (USD)
Period ending	Sales/Maturities of Investments (USD)
Dec 31, 2025	2,000,000
Dec 31, 2024	7,018,000
Dec 31, 2023	63,526,000
Dec 31, 2022	7,666,000
Dec 31, 2021	-6,024,000
Dec 31, 2020	-4,560,000
Dec 31, 2019	14,215,000
Dec 31, 2018	24,815,000
Dec 31, 2017	0
Dec 31, 2016	748,000
Dec 31, 2015	0
Dec 31, 2014	0
Dec 31, 2013	0
Dec 31, 2012	0
Dec 31, 2011	0
Dec 31, 2010	0
Dec 31, 2009	0
Dec 31, 2008	0
Dec 31, 2007	0
Dec 31, 2006	0
Dec 31, 2005	0
Dec 31, 2004	0
Dec 31, 2003	0
Dec 31, 2002	0
Dec 31, 2001	0
Dec 31, 2000	0
Dec 31, 1999	0
Dec 31, 1998	0
Jun 30, 1998	0
Jun 30, 1996	0
Jun 30, 1995	8,000,000
Jun 30, 1994	1,900,000
Jun 30, 1993	0
Jun 30, 1992	0